Alternative Medicine News

EVERGREEN, Colo.--(BUSINESS WIRE)--On Tuesday, April 15, Frontiers in Oncology published the largest meta-analysis ever conducted on medical cannabis and its effects on cancer-related symptoms—a groundbreaking scientific achievement. Led by Cancer Playbook, powered by Whole Health Oncology Institute (WHOI), this systematic research review aggregated data from over 10,000 peer-reviewed studies—a scale never before achieved in this field, and over ten times the number included in the next-largest...

LOS ANGELES--(BUSINESS WIRE)--Bloom, a pioneering national cannabis vape brand recognized for premium quality and product innovation, is proud to announce it has earned ECCO Certification in California — raising the bar for product testing, accountability, and transparency within the cannabis industry. In today’s fragmented cannabis landscape, regulatory enforcement and lab testing standards vary widely across states and markets, often resulting in inconsistent, conflicting product results. ECC...

LAS VEGAS--(BUSINESS WIRE)--Mint Cannabis, one of the nation’s fastest-growing cannabis dispensary operators, is bringing its industry-leading retail experience to Las Vegas with two new dispensaries. This expansion marks the Mint’s official entry into the Nevada market, perfectly timed with the celebration of National Cannabis Day on April 20. Known for its innovative approach to cannabis retail, customer-centric experience, and commitment to quality products, Mint Cannabis aims to elevate the...

WIXOM, Mich.--(BUSINESS WIRE)--Future Pak, LLC (“Future Pak”) today announced that it has submitted two formal proposals since January to acquire all outstanding shares of common stock of Theratechnologies Inc. (“Theratechnologies”) (NASDAQ: THTX). The most recent proposal, which remains open for consideration by Theratechnologies and its Board of Directors, offers a cash consideration of $3.51 to $4.50 per share. The proposal represents a total enterprise value of up to $255 million, comprisin...

NEW YORK--(BUSINESS WIRE)--New national survey reveals shifting views of cannabis, from rising safety concerns to Americans’ desire to consume more cannabis to cope....

RALEIGH, N.C.--(BUSINESS WIRE)--Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, is proud to announce world-renowned actress, director and producer, Salma Hayek Pinault, as the first-ever global brand ambassador for Ultherapy PRIME. Redefining the future in medical aesthetics, Ultherapy PRIME is an advanced micro-focused ultrasound platform for personalized, non-invasive skin lifting.1,2 It is FDA-cleared to lift the skin on the neck, under the chin, and the eyebrows...

RALEIGH, N.C.--(BUSINESS WIRE)--Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, is proud to announce world-renowned actress, director and producer, Salma Hayek Pinault, as the first-ever global brand ambassador for Ultherapy PRIME. Redefining the future in medical aesthetics, Ultherapy PRIME is an advanced micro-focused ultrasound platform for personalized, non-invasive skin lifting.1,2 It is FDA-cleared to lift the skin on the neck, under the chin, and the eyebrows...

RALEIGH, N.C.--(BUSINESS WIRE)--Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, is proud to announce world-renowned actress, director and producer, Salma Hayek Pinault, as the first-ever global brand ambassador for Ultherapy PRIME. Redefining the future in medical aesthetics, Ultherapy PRIME is an advanced micro-focused ultrasound platform for personalized, non-invasive skin lifting.1,2 It is FDA-cleared to lift the skin on the neck, under the chin, and the eyebrows...

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), today announced that it will report its financial results for the first quarter ended March 31, 2025 before U.S. financial markets open on Thursday, May 8, 2025. Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EST. Conference Call and Webcast Details To access the live conference c...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, reaffirms that the manufacturing of its Niagen® ingredient (patented nicotinamide riboside or NR) and Tru Niagen® and pharmaceutical-grade Niagen® products remain resilient amid the recently enacted global tariffs. Manufactured in the U.S. by the Company’s partner, W.R. Grace, Niagen is rig...